Irisin Increases the Expression of Anorexigenic and Neurotrophic Genes in Mouse Brain.
Irisin is a newly discovered muscle-derived hormone, produced by cleavage of the membrane protein fibronectin type III domain-containing protein 5 (FNDC5) and proposed to connect exercise with metabolic homeostasis. In mammals, irisin acts in different organs and tissues improving energy homeostasis. In this study we assessed, for the first time, the effects of intraperitoneal irisin injections on circulating levels leptin and ghrelin, mRNA expression of major appetite regulators (anorexigenic genes: cocaine- and amphetamine-regulated transcript [CART] and pro-opiomelanocortin [POMC]; orexigenic genes: agouti related neuropeptide [AgRP], neuropeptide Y [NPY], orexin [HCRT] and pro-melanin-concentrating hormone [PMCH]; UCP2 and brain-derived neurotrophic factor [BDNF]), and feeding behavior in healthy mice. Twelve male 6-week old C57BL/6 mice were randomized into two groups, and intraperitoneally injected daily with irisin (0.5 μg/g body weight) or vehicle (PBS) for 14 days. On the last day of observation, leptin and ghrelin levels were measured with an ELISA assay. mRNA levels of genes of interest were analyzed by quantitative RT-PCR in brain extracts. Irisin administration did not change leptin or ghrelin serum concentrations. However, irisin injection increased CART, POMC, NPY and BDNF mRNA levels, without affecting the mRNA expression of AgRP, orexin, PMCH and UCP2. Finally, over the time frame of irisin treatment, body weight and feeding behavior were unaltered. These results suggest that intraperitoneal injection of irisin, although without effects on feeding behavior and body weight, can increase the expression of anorexigenic and neurotrophic genes in mouse brain.